94 related articles for article (PubMed ID: 3288646)
1. Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus.
Faller DV; Wilson LD; Flyer DC
J Cell Biochem; 1988 Mar; 36(3):297-309. PubMed ID: 3288646
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
3. Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level.
Wilson LD; Flyer DC; Faller DV
Mol Cell Biol; 1987 Jul; 7(7):2406-15. PubMed ID: 2441241
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H-2 linked Rmv genes are immune response genes controlling the antiviral antibody response.
Debré P; Boyer B; Gisselbrecht S; Bismuth A; Lévy JP
Eur J Immunol; 1980 Dec; 10(12):914-8. PubMed ID: 6781910
[TBL] [Abstract][Full Text] [Related]
5. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.
Green WR; Phillips JD
J Immunol; 1986 Aug; 137(3):814-8. PubMed ID: 3088110
[TBL] [Abstract][Full Text] [Related]
7. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
10. trans-Activation of genes encoding activation-associated human T lymphocyte surface proteins by murine retroviral sequences.
Koka P; van de Mark K; Faller DV
J Immunol; 1991 Apr; 146(7):2417-25. PubMed ID: 2005405
[TBL] [Abstract][Full Text] [Related]
11. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
12. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
13. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
14. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells.
Silverman T; Rein A; Orrison B; Langloss J; Bratthauer G; Miyazaki J; Ozato K
J Immunol; 1988 Jun; 140(12):4378-87. PubMed ID: 2453581
[TBL] [Abstract][Full Text] [Related]
15. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
Sijts AJ; Ossendorp F; Mengedé EA; van den Elsen PJ; Melief CJ
J Immunol; 1994 Jan; 152(1):106-16. PubMed ID: 8254184
[TBL] [Abstract][Full Text] [Related]
16. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
Bonavida B; Katz J
J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
[TBL] [Abstract][Full Text] [Related]
17. MHC class I genes controlling the metastatic phenotype of tumor cells.
Feldman M; Eisenbach L
Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
[TBL] [Abstract][Full Text] [Related]
18. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor.
Plata F; Kalil J; Zilber MT; Fellous M; Lévy D
J Immunol; 1983 Nov; 131(5):2551-6. PubMed ID: 6605389
[TBL] [Abstract][Full Text] [Related]
19. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
Leong C; Marley J; Loh S; Robinson B; Garlepp M
Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
